Evaluation of Silver Nanoparticles for the Prevention of COVID-19

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
In this research, silver nanoparticles (AgNPs) were tested in vitro and shown to have an inhibitory effect on SARS-CoV-2 infection in cultured cells. Subsequently, the investigators assessed the effects of mouthwash and nose rinse with ARGOVIT® silver nanoparticles (AgNPs), in the prevention of SARS-CoV-2 contagion in health workers consider as high-risk group of acquiring the infection in the General Tijuana Hospital, Mexico, a hospital for the exclusive recruitment of patients diagnosed with COVID-19.
Epistemonikos ID: f98a874f6e42e427e1df90a99bc27501d5ff1ad2
First added on: May 21, 2021